Cleared Traditional

DADE(R) CSF.L, LIQ CEREBROSPIN FLUID CTRL LEV 1&2 (K903933) - FDA 510(k) Clearance

Class I Chemistry device.

K903933 · Baxter Healthcare Corp · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1990
Decision
38d
Days
Class 1
Risk

K903933 is an FDA 510(k) clearance for the DADE(R) CSF.L, LIQ CEREBROSPIN FLUID CTRL LEV 1&2. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Baxter Healthcare Corp (Miami, US). The FDA issued a Cleared decision on October 4, 1990 after a review of 38 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Baxter Healthcare Corp devices

Submission Details

510(k) Number K903933 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 27, 1990
Decision Date October 04, 1990
Days to Decision 38 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
50d faster than avg
Panel avg: 88d · This submission: 38d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJY Multi-analyte Controls, All Kinds (assayed)

All 165
Devices cleared under the same product code (JJY) and FDA review panel - the closest regulatory comparables to K903933.
DADE LIID-TROL TL TRI-LEVEL LIPID CONTROL
K911854 · Baxter Healthcare Corp · Jun 1991
QCLYTE PROTEIN BASED ISE CONTROL
K904968 · Baxter Healthcare Corp · Dec 1990
KODATROL I AND II CONTROL AND DILUENT SET
K904768 · Eastman Kodak Company · Nov 1990
DADE IMMUNOASSAY CONTROLS, LEVELS I, II, III
K903566 · Baxter Healthcare Corp · Sep 1990
AFFINITY HLH TEST SYSTEM
K903407 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Sep 1990
PRECINORM(R) IM NORMAL IMMUNOASSAY CONTROL SERUM
K902536 · Boehringer Mannheim Corp. · Jul 1990